These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 38450102)

  • 1. New insights into the role of the oral leukoplakia microenvironment in malignant transformation.
    González-Arriagada WA; Canedo-Marroquin G; Adorno-Farías D; Fernández-Ramires R
    Front Oral Health; 2024; 5():1363052. PubMed ID: 38450102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of smoking status and programmed death-ligand 1 expression on the microenvironment and malignant transformation of oral leukoplakia: A retrospective cohort study.
    Yagyuu T; Funayama N; Imada M; Kirita T
    PLoS One; 2021; 16(4):e0250359. PubMed ID: 33861793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of cornulin, keratin 4, keratin 13 expression and grade of dysplasia for predicting malignant progression of oral leukoplakia.
    Schaaij-Visser TB; Bremmer JF; Braakhuis BJ; Heck AJ; Slijper M; van der Waal I; Brakenhoff RH
    Oral Oncol; 2010 Feb; 46(2):123-7. PubMed ID: 20036603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignant transformation of oral leukoplakia is associated with macrophage polarization.
    Weber M; Wehrhan F; Baran C; Agaimy A; Büttner-Herold M; Öztürk H; Neubauer K; Wickenhauser C; Kesting M; Ries J
    J Transl Med; 2020 Jan; 18(1):11. PubMed ID: 31910881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. E-cadherin as a potential biomarker of malignant transformation in oral leukoplakia: a retrospective cohort study.
    von Zeidler SV; de Souza Botelho T; Mendonça EF; Batista AC
    BMC Cancer; 2014 Dec; 14():972. PubMed ID: 25518919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incorporation of differentiated dysplasia improves prediction of oral leukoplakia at increased risk of malignant progression.
    Wils LJ; Poell JB; Evren I; Koopman MS; Brouns EREA; de Visscher JGAM; Brakenhoff RH; Bloemena E
    Mod Pathol; 2020 Jun; 33(6):1033-1040. PubMed ID: 31896811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early changes in the immune microenvironment of oral potentially malignant disorders reveal an unexpected association of M2 macrophages with oral cancer free survival.
    Bouaoud J; Foy JP; Tortereau A; Michon L; Lavergne V; Gadot N; Boyault S; Valantin J; De Souza G; Zrounba P; Bertolus C; Bendriss-Vermare N; Saintigny P
    Oncoimmunology; 2021; 10(1):1944554. PubMed ID: 34239777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High density of CD8 T cell and immune imbalance of T lymphocytes subsets are associated with proliferative verrucous leukoplakia.
    Fernandes D; Barbeiro CO; Palaçon MP; Biancardi MR; Ferrisse TM; Silveira HA; Castilho RM; de Almeida LY; Leon JE; Bufalino A
    Immunology; 2023 Jan; 168(1):96-109. PubMed ID: 36056642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral leukoplakia: a clinicopathological review.
    van der Waal I; Schepman KP; van der Meij EH; Smeele LE
    Oral Oncol; 1997 Sep; 33(5):291-301. PubMed ID: 9415326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant Transformation and Long-Term Outcome of Oral and Laryngeal Leukoplakia.
    Bukovszky B; Fodor J; Tóth E; Kocsis ZS; Oberna F; Ferenczi Ö; Polgár C
    J Clin Med; 2023 Jun; 12(13):. PubMed ID: 37445290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of differentiated dysplasia in the prediction of malignant transformation of oral leukoplakia.
    Wils LJ; Poell JB; Peferoen LAN; Evren I; Brouns ER; de Visscher JGAM; van der Meij EH; Brakenhoff RH; Bloemena E
    J Oral Pathol Med; 2023 Nov; 52(10):930-938. PubMed ID: 37749621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive value of the combination of SMAD4 expression and lymphocyte infiltration in malignant transformation of oral leukoplakia.
    Sakata J; Yoshida R; Matsuoka Y; Nagata M; Hirosue A; Kawahara K; Nakamura T; Nakamoto M; Hirayama M; Takahashi N; Nakashima H; Arita H; Ogi H; Hiraki A; Shinohara M; Nakayama H
    Cancer Med; 2017 Apr; 6(4):730-738. PubMed ID: 28256094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral premalignant lesions: from a clinical perspective.
    Amagasa T; Yamashiro M; Uzawa N
    Int J Clin Oncol; 2011 Feb; 16(1):5-14. PubMed ID: 21225307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MAGE-A expression in oral and laryngeal leukoplakia predicts malignant transformation.
    Baran CA; Agaimy A; Wehrhan F; Weber M; Hille V; Brunner K; Wickenhauser C; Siebolts U; Nkenke E; Kesting M; Ries J
    Mod Pathol; 2019 Jul; 32(8):1068-1081. PubMed ID: 30936424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignant transformation of oral leukoplakia: a follow-up study.
    Jayasooriya PR; Dayaratne K; Dissanayake UB; Warnakulasuriya S
    Clin Oral Investig; 2020 Dec; 24(12):4563-4569. PubMed ID: 32436158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-cell transcriptomics dissects premalignant progression in proliferative verrucous leukoplakia.
    Zhong L; Wang F; Liu D; Kuang W; Ji N; Li J; Zeng X; Li T; Dan H; Chen Q
    Oral Dis; 2024 Mar; 30(2):172-186. PubMed ID: 35950708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PD-1/PD-L1, Treg-related proteins, and tumour-infiltrating lymphocytes are associated with the development of oral squamous cell carcinoma.
    Kujan O; Agag M; Smaga M; Vaishnaw Y; Idrees M; Shearston K; Farah CS
    Pathology; 2022 Jun; 54(4):409-416. PubMed ID: 34872754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of octamer-binding transcription factor-4 expression in oral leukoplakia.
    Tegginamani AS; Shivakumar VH; Kallarakkal TG; Ismail SM; Abraham MT; Bin Zamzuri AT
    J Oral Maxillofac Pathol; 2020; 24(2):400. PubMed ID: 33456258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Importance of the PD-1/PD-L1 Axis for Malignant Transformation and Risk Assessment of Oral Leukoplakia.
    Ries J; Agaimy A; Wehrhan F; Baran C; Bolze S; Danzer E; Frey S; Jantsch J; Möst T; Büttner-Herold M; Wickenhauser C; Kesting M; Weber M
    Biomedicines; 2021 Feb; 9(2):. PubMed ID: 33669300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical study of syndecan-1 down-regulation and the expression of p53 protein or Ki-67 antigen in oral leukoplakia with or without epithelial dysplasia.
    Kurokawa H; Matsumoto S; Murata T; Yamashita Y; Tomoyose T; Zhang M; Fukuyama H; Takahashi T
    J Oral Pathol Med; 2003 Oct; 32(9):513-21. PubMed ID: 12969225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.